Market Research Report

Companion Diagnostic Market, Global Outlook and Forecast 2022-2028

  • AMR ID : MMG-2488199
  • CAT ID : 7
  • Pages : 92
  • Date : Apr 2022
 

A companion diagnostic device is a special type of invitro medical device that provides information, which is necessary for the effective and safe use of an analogous drug or biological product. Companion diagnostics are developed simultaneously with drugs to help include or exclude a certain group of patients for treatment with a particular drug based on their biological characteristics, which determines patients who respond and those who dont respond to the therapy.
This report contains market size and forecasts of Companion Diagnostic in Global, including the following market information:
Global Companion Diagnostic Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Companion Diagnostic market was valued at 9075.3 million in 2021 and is projected to reach US$ 31360 million by 2028, at a CAGR of 19.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Immunohistochemistry Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Companion Diagnostic include Roche Holdings, Abbott Laboratories, Thermo Fisher Scientific, Agilent Technologies, Merck, Agendia, Qiagen, Myriad Genetics and Advanced Cell Diagnostics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Companion Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Companion Diagnostic Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Companion Diagnostic Market Segment Percentages, by Type, 2021 (%)
Immunohistochemistry
Molecular Diagnosis
Global Companion Diagnostic Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Companion Diagnostic Market Segment Percentages, by Application, 2021 (%)
Oncology
Cardiovascular
Central Nervous System
Virology
Others
Global Companion Diagnostic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Companion Diagnostic Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Companion Diagnostic revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Companion Diagnostic revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche Holdings
Abbott Laboratories
Thermo Fisher Scientific
Agilent Technologies
Merck
Agendia
Qiagen
Myriad Genetics
Advanced Cell Diagnostics
Danaher
Illumina, Inc

1 Introduction to Research & Analysis Reports
1.1 Companion Diagnostic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Companion Diagnostic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Companion Diagnostic Overall Market Size
2.1 Global Companion Diagnostic Market Size: 2021 VS 2028
2.2 Global Companion Diagnostic Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Companion Diagnostic Players in Global Market
3.2 Top Global Companion Diagnostic Companies Ranked by Revenue
3.3 Global Companion Diagnostic Revenue by Companies
3.4 Top 3 and Top 5 Companion Diagnostic Companies in Global Market, by Revenue in 2021
3.5 Global Companies Companion Diagnostic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Companion Diagnostic Players in Global Market
3.6.1 List of Global Tier 1 Companion Diagnostic Companies
3.6.2 List of Global Tier 2 and Tier 3 Companion Diagnostic Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Companion Diagnostic Market Size Markets, 2021 & 2028
4.1.2 Immunohistochemistry
4.1.3 Molecular Diagnosis
4.2 By Type - Global Companion Diagnostic Revenue & Forecasts
4.2.1 By Type - Global Companion Diagnostic Revenue, 2017-2022
4.2.2 By Type - Global Companion Diagnostic Revenue, 2023-2028
4.2.3 By Type - Global Companion Diagnostic Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Companion Diagnostic Market Size, 2021 & 2028
5.1.2 Oncology
5.1.3 Cardiovascular
5.1.4 Central Nervous System
5.1.5 Virology
5.1.6 Others
5.2 By Application - Global Companion Diagnostic Revenue & Forecasts
5.2.1 By Application - Global Companion Diagnostic Revenue, 2017-2022
5.2.2 By Application - Global Companion Diagnostic Revenue, 2023-2028
5.2.3 By Application - Global Companion Diagnostic Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Companion Diagnostic Market Size, 2021 & 2028
6.2 By Region - Global Companion Diagnostic Revenue & Forecasts
6.2.1 By Region - Global Companion Diagnostic Revenue, 2017-2022
6.2.2 By Region - Global Companion Diagnostic Revenue, 2023-2028
6.2.3 By Region - Global Companion Diagnostic Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Companion Diagnostic Revenue, 2017-2028
6.3.2 US Companion Diagnostic Market Size, 2017-2028
6.3.3 Canada Companion Diagnostic Market Size, 2017-2028
6.3.4 Mexico Companion Diagnostic Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Companion Diagnostic Revenue, 2017-2028
6.4.2 Germany Companion Diagnostic Market Size, 2017-2028
6.4.3 France Companion Diagnostic Market Size, 2017-2028
6.4.4 U.K. Companion Diagnostic Market Size, 2017-2028
6.4.5 Italy Companion Diagnostic Market Size, 2017-2028
6.4.6 Russia Companion Diagnostic Market Size, 2017-2028
6.4.7 Nordic Countries Companion Diagnostic Market Size, 2017-2028
6.4.8 Benelux Companion Diagnostic Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Companion Diagnostic Revenue, 2017-2028
6.5.2 China Companion Diagnostic Market Size, 2017-2028
6.5.3 Japan Companion Diagnostic Market Size, 2017-2028
6.5.4 South Korea Companion Diagnostic Market Size, 2017-2028
6.5.5 Southeast Asia Companion Diagnostic Market Size, 2017-2028
6.5.6 India Companion Diagnostic Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Companion Diagnostic Revenue, 2017-2028
6.6.2 Brazil Companion Diagnostic Market Size, 2017-2028
6.6.3 Argentina Companion Diagnostic Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Companion Diagnostic Revenue, 2017-2028
6.7.2 Turkey Companion Diagnostic Market Size, 2017-2028
6.7.3 Israel Companion Diagnostic Market Size, 2017-2028
6.7.4 Saudi Arabia Companion Diagnostic Market Size, 2017-2028
6.7.5 UAE Companion Diagnostic Market Size, 2017-2028
7 Players Profiles
7.1 Roche Holdings
7.1.1 Roche Holdings Corporate Summary
7.1.2 Roche Holdings Business Overview
7.1.3 Roche Holdings Companion Diagnostic Major Product Offerings
7.1.4 Roche Holdings Companion Diagnostic Revenue in Global Market (2017-2022)
7.1.5 Roche Holdings Key News
7.2 Abbott Laboratories
7.2.1 Abbott Laboratories Corporate Summary
7.2.2 Abbott Laboratories Business Overview
7.2.3 Abbott Laboratories Companion Diagnostic Major Product Offerings
7.2.4 Abbott Laboratories Companion Diagnostic Revenue in Global Market (2017-2022)
7.2.5 Abbott Laboratories Key News
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Corporate Summary
7.3.2 Thermo Fisher Scientific Business Overview
7.3.3 Thermo Fisher Scientific Companion Diagnostic Major Product Offerings
7.3.4 Thermo Fisher Scientific Companion Diagnostic Revenue in Global Market (2017-2022)
7.3.5 Thermo Fisher Scientific Key News
7.4 Agilent Technologies
7.4.1 Agilent Technologies Corporate Summary
7.4.2 Agilent Technologies Business Overview
7.4.3 Agilent Technologies Companion Diagnostic Major Product Offerings
7.4.4 Agilent Technologies Companion Diagnostic Revenue in Global Market (2017-2022)
7.4.5 Agilent Technologies Key News
7.5 Merck
7.5.1 Merck Corporate Summary
7.5.2 Merck Business Overview
7.5.3 Merck Companion Diagnostic Major Product Offerings
7.5.4 Merck Companion Diagnostic Revenue in Global Market (2017-2022)
7.5.5 Merck Key News
7.6 Agendia
7.6.1 Agendia Corporate Summary
7.6.2 Agendia Business Overview
7.6.3 Agendia Companion Diagnostic Major Product Offerings
7.6.4 Agendia Companion Diagnostic Revenue in Global Market (2017-2022)
7.6.5 Agendia Key News
7.7 Qiagen
7.7.1 Qiagen Corporate Summary
7.7.2 Qiagen Business Overview
7.7.3 Qiagen Companion Diagnostic Major Product Offerings
7.7.4 Qiagen Companion Diagnostic Revenue in Global Market (2017-2022)
7.7.5 Qiagen Key News
7.8 Myriad Genetics
7.8.1 Myriad Genetics Corporate Summary
7.8.2 Myriad Genetics Business Overview
7.8.3 Myriad Genetics Companion Diagnostic Major Product Offerings
7.8.4 Myriad Genetics Companion Diagnostic Revenue in Global Market (2017-2022)
7.8.5 Myriad Genetics Key News
7.9 Advanced Cell Diagnostics
7.9.1 Advanced Cell Diagnostics Corporate Summary
7.9.2 Advanced Cell Diagnostics Business Overview
7.9.3 Advanced Cell Diagnostics Companion Diagnostic Major Product Offerings
7.9.4 Advanced Cell Diagnostics Companion Diagnostic Revenue in Global Market (2017-2022)
7.9.5 Advanced Cell Diagnostics Key News
7.10 Danaher
7.10.1 Danaher Corporate Summary
7.10.2 Danaher Business Overview
7.10.3 Danaher Companion Diagnostic Major Product Offerings
7.10.4 Danaher Companion Diagnostic Revenue in Global Market (2017-2022)
7.10.5 Danaher Key News
7.11 Illumina, Inc
7.11.1 Illumina, Inc Corporate Summary
7.11.2 Illumina, Inc Business Overview
7.11.3 Illumina, Inc Companion Diagnostic Major Product Offerings
7.11.4 Illumina, Inc Companion Diagnostic Revenue in Global Market (2017-2022)
7.11.5 Illumina, Inc Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

 
Choose License Type

Single User : $3250


Corporate User : $4225


Request Sample Report

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, AMR offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Subscribe Newsletter

  Subscribe